A proposal of screening guideline for retinopathy of prematurity in Taiwan

Mei-Chih Chiang1, Jen-Ruey Tang, Kuo-Inn Tsou Yau

  • 1Department of Pediatrics, St. Martin de Porres Hospital, Chiayi, Taiwan.

Acta Paediatrica Taiwanica = Taiwan Er Ke Yi Xue Hui Za Zhi
|September 20, 2002
PubMed

Insights

This study suggests adjusting retinopathy of prematurity (ROP) screening criteria in Taiwan. Lowering screening to infants under 31 weeks gestational age or 1500g birth weight reduces screenings without missing significant ROP cases.

Area of Science:

  • Neonatal Ophthalmology
  • Public Health
  • Pediatric Medicine

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of morbidity in premature infants.
  • Current American Academy of Pediatrics (AAP) guidelines recommend ROP screening for infants with birth weights ≤ 1500g or gestational ages (GA) ≤ 28 weeks.

Purpose of the Study:

  • To determine optimal ROP screening criteria (birth weight and GA) for premature infants in Taiwan.
  • To evaluate the impact of adjusting screening guidelines on the number of infants requiring evaluation and the detection of ROP.

Main Methods:

  • Retrospective review of 617 premature infants born at National Taiwan University Hospital (1994-1999).
  • Infants survived >28 days and received eye-ground evaluation.
  • Analysis of maximal ROP stage observed based on birth weight and GA.

Main Results:

  • No ROP beyond stage I was observed in infants with birth weights >1500g and GA >31 weeks.
  • Adjusting screening criteria to birth weight ≤1500g or GA ≤31 weeks reduced the number of infants screened by 37.2% without missing ROP > stage 1.
  • Using AAP's GA ≤28 weeks criteria would have missed five cases of stage 2 ROP.

Conclusions:

  • Recommended ROP screening criteria for tertiary nurseries in Taiwan: GA ≤31 weeks or birth weight ≤1500g.
  • These adjusted criteria reduce screening burden while maintaining detection efficacy.
  • Physician discretion is advised for screening larger infants at high risk for ROP.